ePatch and Electropen
Frugal electroporation for vaccine delivery
Imagine a simple, low-cost, and portable tool that could be used to do field experiments in molecular biology or vaccinate billions across the world, all using the principles of a bbq lighter.
Electroporation is a powerful tool in molecular biology labs but has remained inaccessible for many due to its high costs, lack of portability, and need for power. The same challenges have prevented its usage in vaccine delivery, particularly for DNA and mRNA vaccines.
To harness electroporation and enable wider usage, we developed an ultra-low-cost (<$1), portable (<50g), and battery-free electroporation system called “ElectroPen” to bring the power of synthetic biology to budget-conscious laboratories and field researchers.
By integrating a modified version of this platform with microneedles, we developed “ePatch” to improve the safety, affordability, and scalability of nucleic acid medicines. Our broader focus is on global health and bridging the gap with access to RNA and DNA medicines in lower-and-middle income countries (LMIC)— a key barrier witnessed during the COVID-19 pandemic.
To translate this platform to market and accomplish this goal, Piezo Therapeutics was spun out of the Bhamla and Prausnitz Labs and backed by Open Philanthropy in its recent fundraising round.
These projects have been featured in scientific american.
Major questions
What are the basic principles of electroporation?
Can we use an everyday item to accomplish the same principle but with a different mechanism?
How can we leverage a new ultra-low-cost electroporation platform for vaccine delivery?
What we’ve discovered
Read the papers
Tolerability of a piezoelectric microneedle electroporator inhuman subjects (2024).
An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination. PNAS (2021).
Frugal Science Powered by Curiosity. Industrial & Engineering Chemistry Research (2021).
ElectroPen: An ultralow-cost piezoelectric electroporator. PLOS Biology (2020).